Details
 

December 5, 2018

Safe Opioid Prescribing

Harrogate, TN

Wednesday, December 5, 2018
5:30 - 7:30 p.m. (EST)
Updated in 2018, the revised CO*RE curriculum presents safe opioid prescribing in the larger context of pain. The new curriculum includes coverage of Immediate Release (IR) opioids, reference to the CDC Guidelines, updated statistics, and revised case studies.
 
Target Audience:
 Health care providers involved in the management of pain
 
This FREE interactive CME program is being offered 
LIVE IN PERSON at the LMU-DCOM campus
 
6965 Cumberland Gap Parkway
Harrogate, TN  37752
DCOM Room 105
 
or you may LOG IN DIRECTLY FROM YOUR COMPUTER 
to view the ZOOM webinar. 
 
After registering and completing the pre-test,  you will be contacted in advance of the CME program with directions on how to log in on the day of the program and complete CME requirements. You will be able to download a copy of your certificate online. 
 
Course assessment also meets grant requirements for the ER/LA Opioid Analgesics REMS education issued by the US Food & Drug Administration.
 
Light dinner will be provided for on-site attendees at the LMU-DCOM campus
Satisfies FDA Suggested CE/CME on Opioid Prescribing
 
Pain Management and Opioids: Balancing Risks and Benefits meets the State of Tennessee Board of Medical Examiners and Tennessee Board of Osteopathic Examination continuing medical education requirement of two hours every two years of controlled substance prescribing to include Tennessee Chronic Pain Guidelines.
To Register
(Deadline to register: December 1, 2018)
 
 
or use your QR code reader 
SPEAKER
 
Mark Bailey, DO, PhD, FACN
Professor of Neurology and Anesthesiology 
University of Birmingham (UAB), Birmingham, AL
Board Certified in Neurology and Pain
Fellow, and Board of Governors
 American College of Osteopathic Neurologists and Psychiatrists 
Questions? Please contact Patricia Stubenberg, PhD at
Acknowledgement:
 
This program is presented by the American Osteopathic Association, a member of the Collaborative on REMS Education (CO*RE), 13 interdisciplinary organizations working together to improve pain management and prevent adverse outcomes
The Collaborative for REMS Education, or CO*RE, is a 13-partner collaboration dedicated to providing members with effective, high quality education about ER/LA opioids, bridging practice gaps in this challenging clinical area and improving patient care. The mission of CO*RE is to promote individual and population health and public safety through timely, evidence-based, outcome-oriented and inter professional education related to the comprehensive management of pain, addiction, and their co-morbidities. Since 2013 CO*RE and its partner organizations have educated more than 155,000 prescribing clinicians across the country.
 
RPC Commercial Support Disclosure Statement:
 
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies.  Please see http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of the member companies.  This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.

 

Printer-Friendly Version


2018-12-05 2018-12-05 America/Detroit Safe Opioid Prescribing Wednesday, December 5, 2018 5:30 - 7:30 p.m. (EST) Updated in 2018, the revised CO*RE curriculum presents safe opioid prescribing in the larger context of pain. The new curriculum includes coverage of Immediate Release (IR) opioids, reference to the CDC Guidelines, updated statistics, and revised case studies.   Target Audience:  Health care providers involved in the management of pain   This FREE interactive CME program is being offered  LIVE IN PERSON at the LMU-DCOM campus   6965 Cumberland Gap Parkway Harrogate, TN  37752 DCOM Room 105   or you may LOG IN DIRECTLY FROM YOUR COMPUTER  to view the ZOOM webinar.    After registering and completing the pre-test,  you will be contacted in advance of the CME program with directions on how to log in on the day of the program and complete CME requirements. You will be able to download a copy of your certificate online.    Course assessment also meets grant requirements for the ER/LA Opioid Analgesics REMS education issued by the US Food & Drug Administration.   Light dinner will be provided for on-site attendees at the LMU-DCOM campus Satisfies FDA Suggested CE/CME on Opioid Prescribing   Pain Management and Opioids: Balancing Risks and Benefits meets the State of Tennessee Board of Medical Examiners and Tennessee Board of Osteopathic Examination continuing medical education requirement of two hours every two years of controlled substance prescribing to include Tennessee Chronic Pain Guidelines. To Register (Deadline to register: December 1, 2018)   CLICK HERE    or use your QR code reader  SPEAKER   Mark Bailey, DO, PhD, FACN Professor of Neurology and Anesthesiology  University of Birmingham (UAB), Birmingham, AL Board Certified in Neurology and Pain Fellow, and Board of Governors  American College of Osteopathic Neurologists and Psychiatrists  Questions? Please contact Patricia Stubenberg, PhD at patricia.stubenberg@lmunet.edu or 423-869-6819 Acknowledgement:   This program is presented by the American Osteopathic Association, a member of the Collaborative on REMS Education (CO*RE), 13 interdisciplinary organizations working together to improve pain management and prevent adverse outcomes The Collaborative for REMS Education, or CO*RE, is a 13-partner collaboration dedicated to providing members with effective, high quality education about ER/LA opioids, bridging practice gaps in this challenging clinical area and improving patient care. The mission of CO*RE is to promote individual and population health and public safety through timely, evidence-based, outcome-oriented and inter professional education related to the comprehensive management of pain, addiction, and their co-morbidities. Since 2013 CO*RE and its partner organizations have educated more than 155,000 prescribing clinicians across the country.   RPC Commercial Support Disclosure Statement:   This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies.  Please see http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of the member companies.  This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.   Harrogate, TN